диссертации / 130
.pdf148.Cai, H. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress / H. Cai, D.G. Harrison // Circ. Res. – 2000. – Vol.87(10). – P. 840844.
149.Cardillo, C. Role of endothelin in the increased vascular tone of patients with essential hypertension / C. Cardillo, C.M. Kilcone, M. Waclawiw, R.O. Cannon 3rd, J.A. Panza // Hypertension. - 1999. - Vol.33. - P. 753–758.
150.Celermajer, D.S. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects related to coronary risk factors and their interaction / D.S. Celermajer, K.E. Sorensen, C. Bull, J. Robinson, J.E. Deanfield // J.Am. Coll. Cardiol. - 1994. - Vol. 24(6). - P. 1468-1474.
151.Celermajer, D.S. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis / D.S. Celermajer, K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, I.D. Sullivan, J.K. Lloyd, J.E. Deanfield // Lancet. - 1992. - Vol. 7;340 (8828). - P. 1111-1115.
152.Celermajer, D.S. Nitric oxide (NO), vascular protection factor. NO: role in aging / D.S. Celermajer, A. Tiritilli // Presse Med. - 1998. - Vol. 13(21). - P. 1071-1072.
153.Chhabra, N. Endothelial dysfunction – a predictor of atherosclerosis / N. Chhabra // Internet J. Med. Update. - 2009. - Vol. 4(1). - P. 33–41.
154.Cherchi, A. Antianginal and antiischemic activity of nebivolol in stable angina of effort / A. Cherchi, C. Lai, R. Pirisi, E. Onnis // Drug Invest. - 1991. - V. 3. - Suppl 1. - P. 86-98.
155.Chin-Dusting, J.P. Human forearm venous occlusion plethysmography: methodology, presentation and analysis / J.P. Chin-Dusting, J.D. Cameron, A.M. Dart, G.L. Jennings // Clin. Sci. (Lond). - 1999. - Vol. 96(5). - P. 439-440.
161
156.Cines, D.B. Endothelial cells in physiology and in the pathophysiology of vascular disorders / D.B. Cines, E.S. Pollak, C.A. Buck, J. Loscalzo, G.A. Zimmerman, R.P. McEver, J.S. Pober, T.M. Wick, B.A. Konkle, B.S. Schwartz, E.S. Barnathan, K.R. McCrae, B.A. Hug, A.M. Schmidt, D.M. Stern // Blood. - 1998. - Vol. 91(10). - P. 3527-3261.
157.Clozel, M. Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension / M. Clozel // Hypertension. - 1991. - Vol. 18(4 Suppl). - P. 37-42.
158.Cockcroft, J.R. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism / J.R. Cockcroft, P.J. Chowienczyk, S.E. Brett, C.P. Chen, A.G. Dupont, L. Van Nueten, S.J. Wooding, J.M. Ritter // J. Pharmacol. Exp. Ther. - 1995. - Vol. 274(3). - P. 1067-1071.
159.Cooke, J.P. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ / J.P. Cooke // Clin. Cardiol. - 1997. - Vol.II. - P. 4551.
160.Cooke, J.P. Is NO an endogenous antiatherogenic molecule? / J.P. Cooke, P.S. Tsao // Arterioscler. Thromb. - 1994. - Vol. 14. - P. 653-655.
161.Corretti, M.C. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force / M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, M.A. Creager, J. Deanfield, H. Drexler, M. Gerhard-Herman, D. Herrington, P. Vallance, J. Vita, R. Vogel // J. Am. Coll. Cardiol. - 2002. - Vol. 16;39(2). - P. 257-265.
162.Cosentino, F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells / F. Cosentino, K. Hishikawa, Z.S. Katusic, T.F. Lusher // Circulation. - 1997. - Vol. 96. - P. 2528.
162
163.Creager, M.A. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans / M.A. Creager, S.J. Gallagher, X.J. Girerd, S.M. Coleman, V.J. Dzau, J.P. Cooke // J.Clin. Invest. - 1992. - Vol. 90. -P. 1242-1253.
164.Crouse, J.R. Arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement. The ARIC Investigators / J.R. Crouse, U. Goldbourt, G. Evans et al. // Stroke. - 1994. - V.25. - P.1354–1359.
165.Dart, C. Lipid microdomains and the regulation of ion channel function / C. Dart // J. Physiol. - 2010. - Vol. 588. - P. 3169-3178.
166.Davis, S.F. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant / S.F. Davis, A.C. Yeung, I.T. Meredith, F. Charbonneau, P. Ganz, A.P. Selwyn, T.J. Anderson // Circulation. - 1996. - Vol. 93. - P. 457-462.
167.Dawes, M. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension / M. Dawes, S.E. Brett, P.J. Chowienczyk, T.G. Mant, J.M. Ritter //Br. J. Clin. Pharmacol. - 1999. - Vol. 48. - N3. - P. 460463.
168.DeLano, F.A. Penetration of the systemic blood pressure into the microvasculature of rat skeletal muscle / F.A. DeLano, G.W. Schmid-Schonbein, T.C. Skalak, B.W. Zweifach // Microvasc. Res. - 1991. - Vol. 41. - P. 92–110.
169.Ding, Y. Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression / Y. Ding, N.D. Vaziri // J. Pharmacol. Exp. Ther. - 2000. - Vol. 292(2). - P. 606-609.
170.Ding, Y. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells / Y. Ding, N.D. Vaziri // Hypertension. - 1998. - V. 32(4). - P. 718-723.
163
171. Dobarro, D. Current pharmacological approach to restore endothelial dysfunction / D. Dobarro, M.C. Gómez-Rubín, A. Sanchez-Recalde, R. Moreno, G. Galeote, S. Jimenez-Valero, L. Calvo, E. López de Sá, J.L. López-Sendón //
Cardiovasc. Hematol.Agents Med. Chem. - 2009.Vol. 7(3). - P. 212-222.
172.Dohi, Y. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries / Y. Dohi, L. Criscione, K. Pfeiffer, T.F. Luscher // J. Cardiovasc. Pharmacol. - 1994. - Vol. 24(3). - P. 372-379.
173.Dominiczak, A.F. Nitric oxide and its putative role in hypertension / A.F. Dominiczak, D.F. Bohr // Hypertension. – 1995. – Vol.25. – P. 1202-1211.
174.Drexler, H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine / H. Drexler, A.M. Zeiher, K. Meinzer, H. Just // Lancet. - 1991. - Vol.338 (8782-8783). - P. 1546-1550.
175.Drexler, H. Nitric oxide and coronary endothelial dysfunction in humans / H. Drexler // Cardiovasc. Res. - 1999. - Vol. 43. - P. 572-579.
176.Du, C. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? / C. Du, R. Hu, C.A. Csernamsky et al. // J. Cereb. Blood Flow Metab. - 1996. - Vol.16. - P. 195-201.
177.Duffy, S.J. Antioxidants and endothelial function / S.J. Duffy, J.A. Vita, J.F. Keaney // Heart Failure. – 1999. – Vol.15. – P.135-152.
178.Dzau, V.J. Endothelium and growth factors in vascular remodeling of hypertension / V.J. Dzau, G.N. Gibbons // Hypertension. - 1991. - Vol.18 (5 suppl). - P.III115-III121.
179.English, J.L. Effect of the menstrual cycle on endothelium-dependent vasodilation of the brachial artery in normal young women / J.L. English, L.O. Jacobs, G. Green, T.C. Andrews // Am. J. Cardiol. 1998. - Vol. 82(2). - P. 256-258.
164
180. Esper, R.J. Endothelial dysfunction: a comprehensive appraisal / R.J. Esper, R.A. Nordaby, J.O. Vilarino, et al. // Cardiovascular Diabetology.- 2006. – Vol. 5(4). P. 1-18.
181.Faraci, F.M. Regulation of the cerebral circulation: role of endothelium and potassium channels / F.M. Faraci, D.D. Heistad // Physiol. Reviews. - 1998. – Vol. 78(1). –P.53-97.
182.Fegan, P.G. Capillary pressure in subjects with type 2 diabetes and hypertension and the effect of antihypertensive therapy / P.G. Fegan, J.E. Tooke, K.M. Gooding, J.M. Tullett, K.M. MacLeod, A.C. Shore // Hypertension. - 2003. - Vol. 41(5). - P. 1111-1117.
183.Feihl, F. Hypertension: A Disease of the Microcirculation / F. Feihl, L. Liaudet, B. Waeber, B. Levy // Hypertension. - 2006. - №48. - P. 1012-1017.
184.Feliciano, L. Coronary artery blood flow: physiologic and pathophysiologic regulation / L. Feliciano, R.J. Henning // Clin. Cardiol. - 1999. - Vol. 22. - P. 775-786.
185.Ferrara, L.A. Carotid diameter and blood flow velocities in hypertensive patients / L.A. Ferrara, M. Mancini, R. Lannuzzi et al. // Stroke. - 1995. - Vol.26. - P. 418-421.
186.Fried, L.P. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study / L.P. Fried, R.A. Kronmal, A.V. Newman // JAMA. - 1998. - Vol. 279(8). - P. 585-592.
187.Fukai, T. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training/ T. Fukai, M.R. Siegfried, M. Ushio-Fukai, et al. // J. Clin. Invest. - 2000. - №105. - P. 1631 -39.
188.Furchgott, R.F. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine / R.F. Furchgott, J.V. Zawadzki // Nature. - 1980. - Vol. 288. - P. 373-376.
165
189.Galley, H.F. Physiology of the endothelium / H.F. Galley, N.R. Webster // Br. J. Anaesth. – 2004. - Vol. 93(1). – P. 105-113.
190.Gao, Y.S. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries / Y.S. Gao, T. Nagao, R.A. Bond, W.J. Janssens, P.M. Vanhoutte // J. Cardiovasc. Pharmacol. - 1991. - Vol. 17. - N6. - P. 964-969.
191.Ghiadoni, L. Different effect of antihypertensive drugs on conduit artery endothelial function / L. Ghiadoni, A. Magagna, D. Versari, et al. // Hypertension. – 2003. - Vol.41. – P.1281-1286.
192.Ghiadoni, L. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension / L. Ghiadoni, A. Virdis, A. Magagna, S. Taddei, A. Salvetti // Hypertension. - 2000. - Vol.35 (1 Pt 2). - P. 501-506.
193.Gibbons, G.H. The emerging concept of vascular remodeling / G.H. Gibbons, V.J. Dzau // N. Engl. J. Med. - 1994. - Vol. 330. - P. 1431-1438.
194.Gokce, N. Clinical manifestations of endothelial dysfunction / N. Gokce, J.A. Vita // In: J. Loscalzo, A.I. Schafer, editors. Thrombosis and Hemorrage. Philadelhia, P.A.: Lippincott Williams & Wilkins. - 2002. P.685-706.
195.Gryglewski, R.J. Prostacyclin, nitric oxide, and atherosclerosis / R.J.
Gryglewski, S. Chłopicki, J. Swies, P. Niezabitowski // Ann. N. Y. Acad. Sci. -
1995. - Vol. 748(2). - P. 194-206.
196.Hahn, A.W. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function / A.W. Hahn, T.J. Resink, Scott- T. Burden, J. Powell, Y. Dohi, F.R. Bühler // Cell. Regulations. - 1990. - Vol.1(9). - P. 649-659.
197.Hamilton, O.E. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis / O.E. Hamilton // N.Engl.J.Med. - 1991. - №325(7). - P. 445-53.
166
198.Harrison, D.G. Endothelial function and oxidant stress / D.G. Harrison
//Clin. Cardiol. - 1997. - №20. - P. 11-17.
199.Harrison, P. Progress in assessment of platelet function / P. Harrison // Br.J. Haemat. - 2000. - V. 111(7). - P. 733-744.
200.Hayward, C.S. Assessment of endothelial function using peripheral waveform analysis: a clinical application / C.S. Hayward, M. Kraidly, C.M. Webb, P. Collins // J. Am. Coll. Cardiol. - 2002. - Vol. 7;40(3). - P. 521-528.
201.Heistad, D.D. Sick vessel syndrome: vascular changes in hypertension and atherosclerosis / D.D. Heistad, G.L. Baumbach, F.M. Faraci, M.L. Armstrong
//J. Hum. Hypertens. - 1995. - Vol. 9(6). - P. 449-453.
202.Heitzer, T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease / T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, T. Munzel // Circulation. – 2001. – Vol.104. – P. 2673-2678.
203.Holland, J.A. Atherogenic levels of low-density lipoprotein increase hydrogen peroxide generation in cultured human endothelial cells: possible mechanism of heightened endocytosis / J.A. Holland, L.M. Ziegler, J.W. Meyer // J. Cell. Physiol. - 1996. - Vol. 166(1). - P. 144-151.
204.Hollander, M. Intima-media thickness at different location of the carotid artery and risk of ischemic stroke and its subtypes: the Rotterdam Study (Abstract) / M. Hollander, M.L. Bots, J.C. Witteman et al. // Stroke. - 2000. - Vol. 31. - P. 280.
205.Huang, A. Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stressand agonist-induced dilations / A. Huang, D. Sun, G. Kaley, A. Koller // Circulation Research. - 1998. - Vol. 83. -P. 960-965.
167
206.Hussein, O. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL / O. Hussein, S. Schlezinger, M. Rosenblat, S. Keidar, M. Aviram // Atherosclerosis. - 1997. - Vol. 128(1). - P. 11-18.
207.Ikeda, U. Inducible nitric oxide synthase and atherosclerosis / U. Ikeda, Y. Maeda, K. Shimada // Clin. Cardiol. - 1998. - Vol. 21. - P. 473-476.
208.Ishide, T. Nitric oxide within periaqueductal gray modulates glutamatergic neurotransmission and cardiovascular responses during mechanical and thermal stimuli / T. Ishide, A. Amer, T.J. Maher, A. Ally // Neurosci Res. - 2005. - Vol. 51(1). - P. 93-103.
209.Jean-Baptiste Michel. NO (Nitric oxide) and Cardiovascular Homeostasis / Jean-Baptiste Michel // Menarini International Industrie Farmaceutiche Riunite s.r.l. Paris. - 1999. - 45 pp.
210.Kingwell, B.A. Enhanced vasodilation to acetylcholine in athletes is associated with lower plasma cholesterol / B.A. Kingwell, B. Tran, J.D. Cameron, G.L. Jennings, A.M. Dart // Am. J. Physiol. 1996. - Vol. 270 (6 Pt 2). - P. H20082013.
211.Kishi, Y. Effect of nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells / Y. Kishi, T. Watanabe, T. Makita, S. Sakita, R. Watanabe, T. Ashikaga, F. Numano // J. Cardiovasc. Pharmacol. - 1995. - Vol. 26.
-P. 590-595.
212.Konishi, M. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries / M.Konishi, C. Su // Hypertension. - 1983.
-Vol. 5. - P. 881-886.
213.Krenek, P. Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats / P. Krenek, S. Salomone, J. Kyselovic, M. Wibo, N. Morel, T. Godfraind // Hypertension. - 2001. - Vol. 37. - P. 1124-1128.
168
214.Kumar, S. Heterogeneity in endothelial cells from large vessels and microvessels / S. Kumar, D.C. West, A. Ager // Differentiation. - 1987. - Vol. 36(1). - P. 57-70.
215.Kuvin, J.T. Assessment of peripheral vascular endothelial function in the ambulatory setting / J.T. Kuvin, A. Mammen, P. Mooney, A.A. Alsheikh-Ali, R.H. Karas // Vasc. Med. - 2007. - Vol. 12(1). - P. 13-16.
216.Landmesser, U. Endothelial function. A critical determinant in atherosclerosis? / U. Landmesser, B. Hornig, H. Drexler // Circulation. – 2004. –
Vol. 109 (suppl II). – P. II-27-II-33.
217.Lassen, N.A. Cerebral blood flow and oxygen consumption in man / N.A. Lassen // Physiol Rev. - 1959. - Vol. 39(2). P. 183-238.
218.Laucevicius, A. First experience with salbutamol - induced changes in the photoplethysmographic digital volume pulse / A. Laucevicius, L. Ryliskyte, Z. Petrulioniene, M. Kovaite, N. Misonis // Seminars in Cardiology. - 2002. - Vol. 8(1). P. 87-93.
219.Lehr, H.A. Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor / H.A. Lehr, J.
Seemüller, C. Hübner, M.D. Menger, K. Messmer // Arterioscler. Thromb. - 1993.
-Vol. 13(7). - P. 1013-1018.
220.Lekakis, J. Effects of acute cigarette smoking on endotheliumdependent arterial dilatation in normal subjects / J. Lekakis, C. Papamichael, C. Vemmos, K. Stamatelopoulos, A. Voutsas, S. Stamatelopoulos // Am. J. Cardiol. - 1998. - Vol. 81(10). - P. 1225-1228.
221.Leung, W.H. Beneficial effect of cholesterollowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients / W.H. Leung, C.P. Lau, C.K. Wong // Lancet. – 1993. – Vol.341. – P. 1496-1500.
222.Lind, L. Endothelium-dependent vasodilation in hypertension: a
review / L. Lind, S.O. Granstam, J. Millgård // Blood Pressure. - 2000. - Vol. 9. -
P. 4-15.
169
223.Lou, J.N. An improved method for isolation of microvascular endothelial cells from normal and inflamed human lung / J.N. Lou, N. Mili, C. Decrind, Y. Donati, S. Kossodo, A. Spiliopoulos, B. Ricou, P.M. Suter, D.R. Morel, P. Morel, G.E. Grau // In Vitro Cell. Dev. Biol. Anim. - 1998. - Vol. 34(7).
-P. 529-536.
224.Lüscher T.F. The endothelium in hypertension: bystander, target or mediator? / T.F. Lüscher // J. Hypertens. Suppl. - 1994. - Vol. 12(10). P. 105-116.
225.Luscher T.F. Endothelial dysfunction as a therapeutic target: the ENCORE trials / T.F. Luscher // European Heart J. - 2000. - V.2 (Supplement D). - P. D20-D25.
226.Lüscher, T.F. Biology of the endothelium / T.F. Lüscher, M. Barton //
Clin. Cardiol. - 1997. - Vol. 20 (11 suppl 2). - P. II-3-10.
227.Luscher, T.F. Endothelium-derived contracting factors / T.F. Luscher, C.M. Boulanger, Y. Dohi, Z.H. Yang // Hypertension. - 1992. - Vol. 19. - №2. - P. 117-130.
228.Luscher, T.F. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats / T.F. Luscher, L. Raij, P.M. Vanhoutte // Hypertension. -1987. -Vol.9 (2). - P. 157-163.
229.Madhavan, S. Renal function during antihypertensive treatment / S. Madhavan, D. Stockwell, H. Cohen et al. // Lancet. - 1995. - №345. - P. 749-751.
230.Madhu, S.V. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus / S.V. Madhu, S. Kant, S. Srivastava, R. Kant, S.B. Sharma, D.P. Bhadoria // Diabetes Res. Clin. Practice. - 2008. - Vol.80. - P. 380-385.
231.Mather, K.J. Improved endothelial function with metformin in type 2 diabetes mellitus / K.J. Mather, S. Verma, T.J. Anderson // J.Am.Coll.Cardiol. –
2001. – Vol.37. – P. 1344-1350.
170